No abstract

Background: There is no recommendation for treating pulmonary hypertension (PH) when associated with chronic obstructive pulmonary disease (COPD). Objective: To evaluate the effect of PH-specific therapy in patients with COPD. Methods: All successive patients with severe PH [mean pulmonary arterial pressure (mPAP) ≥35 mm Hg] and COPD, who received specific PH medication and who underwent right heart catheterization at baseline and after 3-12 months of treatment, were analyzed from a prospective database. Results: Twenty-six patients were included with a median follow-up of 14 months. Mean forced expiratory volume in 1 s was 57 ± 20% of predicted, and mean forced expiratory volume in 1 s/forced vital capacity was 47 ± 12%. Dyspnea was New York Health Association classification stage (NYHA) II in 15%, NYHA III in 81% and NYHA IV in 4%. First-line treatments were endothelin receptor antagonists in 11 patients, phosphodiesterase-5 inhibitors in 11 patients, calcium blocker in 1 patient, combination therapy in 3 patients including 2 with a prostanoid. After 6 ± 3 months, pulmonary vascular resistance decreased from 8.5 ± 3 to 6.6 ± 2 Wood units (p < 0.001), with significant improvement of cardiac index from 2.44 ± 0.43 to 2.68 ± 0.63 liters × min × m^-2 (p = 0.015) and mPAP from 48 ± 9 to 42 ± 10 mm Hg (p = 0.008). There was no significant difference in dyspnea, 6-min walking distance, echocardiographic parameters or N-terminal pro-brain natriuretic peptide levels. There was no significant difference in arterial oxygen saturation after 3-12 months of treatment. Conclusions: Specific PH medications may improve hemodynamic parameters in COPD patients with severe PH. Appropriate prospective randomized studies are needed to evaluate the potential long-term clinical benefit of treatment.

International audienceThis paper investigates the effects of different surface treatments on the mechanical resistance of interface between wires of NiTi shape memory alloy and silicone rubber. Three different treatments were used; primer, plasma and combination of both. The wires deoxidation effects have also been studied. In order to characterize the interface properties in such composite material, pull-out tests were carried out by means of a home-made device. This test allows us to evaluate the mechanical resistance of the interface in terms of the maximum force reached during the test. First, results show that the debonding force is not higher after the wires deoxidation. This preparation is therefore not necessary. Second, using a primer PM820 and plasma separately leads to a significant improvment of the mechanical resistance. Third, the combination of these treatments (primer followed by plasma) and a longer time of exposure to the plasma alone get the debonding force higher. Consequently, NiTi/silicone rubber interface improved only by means of plasma offers a new way to obtain biocompatible interfaces in such composite material

A unique approach based on the colloidal route allowing the synthesis of monodisperse bimetallic, trimetallic, tetrametallic and pentametallic nanoparticles with diameters around 5 nm as solid solutions.